Opdivo nivolumab: Updated Phase I/II data

Updated data from a cohort of 78 patients with metastatic urothelial cancer in the open-label, international Phase I/II CheckMate -032 trial showed

Read the full 229 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE